This is a preview of subscription content, log in via an institution to check access.
Notes
2012 US dollars
Reference
Yeh JM, et al. Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis. Gut : 16 Mar 2015. Available from: URL: http://doi.org/10.1136/gutjnl-2014-308588
Rights and permissions
About this article
Cite this article
Pepsinogen NCGA screening may be cost effective in smokers. PharmacoEcon Outcomes News 724, 23 (2015). https://doi.org/10.1007/s40274-015-2001-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2001-5